MRI monitoring of MS in clinical trials

被引：17

作者：

Miller, DH

机构：

[1] Inst Neurol, NMR Res Unit, London WC1N 3BG, England

[2] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England

来源：

CLINICAL NEUROLOGY AND NEUROSURGERY | 2002年 / 104卷 / 03期

关键词：

MRI; treatment; monitoring; prognosis;

D O I：

10.1016/S0303-8467(02)00045-8

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：236 / 243

页数：8

共 79 条

[1] HISTOLOGICAL, HISTOCHEMICAL AND BIOCHEMICAL-STUDY OF THE MACROSCOPICALLY NORMAL WHITE MATTER IN MULTIPLE-SCLEROSIS [J].

ALLEN, IV ;

MCKEOWN, SR .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1979, 41 (01) :81-91

[2]

Andersen O, 1996, Mult Scler, V1, P348

[3] PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE [J].

ARNOLD, DL ;

MATTHEWS, PM ;

FRANCIS, G ;

ANTEL, J .

MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) :154-159

[4] Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis [J].

Barkhof, F ;

Filippi, M ;

van Waesberghe, JH ;

Molyneux, P ;

Rovaris, M ;

Nijeholt, GLA ;

Tubridy, N ;

Miller, DH ;

Yousry, TA ;

Radue, EW ;

Adèr, HJ .

NEUROLOGY, 1997, 49 (06) :1682-1688

[5] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].

Barkhof, F ;

Filippi, M ;

Miller, DH ;

Scheltens, P ;

Campi, A ;

Polman, CH ;

Comi, G ;

Ader, HJ ;

Losseff, N ;

Valk, J .

BRAIN, 1997, 120 :2059-2069

[6] Multisequence MRI in clinically isolated syndromes and the early development of MS [J].

Brex, PA ;

O'Riordan, JI ;

Miszkiel, KA ;

Moseley, IF ;

Thompson, AJ ;

Plant, GT ;

Miller, DH .

NEUROLOGY, 1999, 53 (06) :1184-1190

[7] Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology [J].

Bruck, W ;

Bitsch, A ;

Kolenda, H ;

Bruck, Y ;

Stiefel, M ;

Lassmann, H .

ANNALS OF NEUROLOGY, 1997, 42 (05) :783-793

[8] Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study [J].

Comi, G ;

Filippi, M ;

Barkhof, F ;

Durelli, L ;

Edan, G ;

Fernández, O ;

Hartung, HP ;

Seeldrayers, P ;

Sorensen, PS ;

Rovaris, M ;

Martinelli, V ;

Hommes, OR .

LANCET, 2001, 357 (9268) :1576-1582

[9] European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis [J].

Comi, G ;

Filippi, M ;

Wolinsky, JS .

ANNALS OF NEUROLOGY, 2001, 49 (03) :290-297

[10] In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis [J].

De Stefano, N ;

Narayanan, S ;

Matthews, PM ;

Francis, GS ;

Antel, JP ;

Arnold, DL .

BRAIN, 1999, 122 :1933-1939

← 1 2 3 4 5 6 7 8 →